| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/26/1996 | CA2156674A1 Cyclohexadiene derivatives |
| 02/26/1996 | CA2156673A1 Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments |
| 02/26/1996 | CA2156672A1 2,3-bridged 1,4-dihydropyridines, processes for their preparation and their use as medicaments |
| 02/24/1996 | CA2156768A1 Pharmaceutical formulations, their preparation and use |
| 02/22/1996 | WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 02/22/1996 | WO1996005301A1 Novel vesicular acetylcholine carrier |
| 02/22/1996 | WO1996005221A1 Calcitonin receptor |
| 02/22/1996 | WO1996005203A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents |
| 02/22/1996 | WO1996005200A1 TETRAHYDROPYRIDINYLMETHYL DERIVATIVES OF PYRROLO[2,3-b]PYRIDINE |
| 02/22/1996 | WO1996005193A1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 02/22/1996 | WO1996005185A1 Novel alkylamino derivatives as sigma 2 selective ligands |
| 02/22/1996 | WO1996005181A1 Morpholine derivatives and their use as therapeutic agents |
| 02/22/1996 | WO1996005175A1 Synthetic excitatory amino acids |
| 02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
| 02/22/1996 | WO1996004901A1 Composition and method for treating anxiety |
| 02/22/1996 | WO1996004900A1 Composition and method for protection against drug dependency |
| 02/22/1996 | WO1996004897A1 Use of selegilin in the treatment of epilectic conditions |
| 02/22/1996 | WO1996004895A1 Anthracyclinone derivatives and their use in amyloidosis |
| 02/22/1996 | WO1996004789A1 A method of selectively destroying neoplastic cells |
| 02/22/1996 | CA2197497A1 Novel vesicular acetylcholine carrier |
| 02/22/1996 | CA2197172A1 Novel alkylamino derivatives as sigma 2 selective ligands |
| 02/22/1996 | CA2195972A1 Morpholine derivatives and their use as therapeutic agents |
| 02/22/1996 | CA2195782A1 Composition and method for treating anxiety |
| 02/22/1996 | CA2195779A1 Composition and method for protection against drug dependency |
| 02/22/1996 | CA2195757A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents |
| 02/22/1996 | CA2173623A1 Anthracyclinone derivatives and their use in amyloidosis |
| 02/21/1996 | EP0697410A1 54-substituted alkylidene 2-(N-cyanoimino)-thiazolidin-4-one derivatives, their preparation and their use as aldose reductase inhibitors |
| 02/21/1996 | EP0697403A1 Derivatives of glycinamides as cholecystokinin receptor agonists |
| 02/21/1996 | EP0697019A1 Risperidone pamoate |
| 02/21/1996 | EP0474767B1 Dopamine agonists |
| 02/21/1996 | CN1117048A A process for preparing an intermediate compound of the benzothiazole compounds |
| 02/21/1996 | CN1117046A Method for preparing pharmaceutically active CNS compounds |
| 02/21/1996 | CN1117044A Substituted N-heteroaroaroylguanidin, preparation, pharmaceutical application and medicine containg same |
| 02/21/1996 | CN1116946A Medicine for abstaining from drugs and its preparation |
| 02/21/1996 | CN1116929A Use of compounds having an anti-glucocorticoid activity for the preparation of medicaments intended caments prevention or treatment of symptoms associated with the syndrome of spontaneous or prec..... |
| 02/20/1996 | US5493026 Labeled with radioactive isotopes for tomography |
| 02/20/1996 | US5492927 Non-peptide tachykinin receptor antagonists to treat allergy |
| 02/20/1996 | US5492923 Drug for treating arterial hypertension and atherosclerosis |
| 02/20/1996 | US5492919 Irritable bowel disorder |
| 02/20/1996 | US5492914 2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[DE]is[2.2.2]oct-3's-yl)-6-hydroxy-2,3,3a,4,5,6-hexahydro-1h-benz [DE]isoquinolin-1-one and individual stereoisomers thereof |
| 02/20/1996 | US5492913 N-benzylpiperazine compounds |
| 02/20/1996 | US5492905 1-bolizazepin-2,5-diones |
| 02/17/1996 | CA2156197A1 Composition and subcompositions of same: process for obtaining them and their molecular identification, and their anti-inflammatory, analgesic, antipruritic and local antipyretic therapeutic effect in human beings and animals |
| 02/15/1996 | WO1996004394A1 Hsv viral vector |
| 02/15/1996 | WO1996004387A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 02/15/1996 | WO1996004314A1 Mhc complexes and uses thereof |
| 02/15/1996 | WO1996004296A1 Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function |
| 02/15/1996 | WO1996004287A1 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
| 02/15/1996 | WO1996004283A1 New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 02/15/1996 | WO1996004274A1 Azetidine, pyrrolidine and piperidine derivatives |
| 02/15/1996 | WO1996004272A1 N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics |
| 02/15/1996 | WO1996004254A2 Benzodiazepine derivatives |
| 02/15/1996 | WO1996004250A1 Benzimidazole derivatives having dopaminergic activity |
| 02/15/1996 | WO1996004245A1 N-substituted azabicycloheptane derivatives useful as neuroleptics |
| 02/15/1996 | WO1996004233A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 02/15/1996 | WO1996003983A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 02/15/1996 | WO1996003982A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
| 02/15/1996 | DE4428444A1 Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen Use of selegiline for the treatment of epileptic disorders |
| 02/15/1996 | CA2196809A1 N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics |
| 02/15/1996 | CA2196701A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 02/15/1996 | CA2196700A1 N-substituted azabicycloheptane derivatives, the preparation aand use thereof |
| 02/15/1996 | CA2196193A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 02/15/1996 | CA2196183A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
| 02/15/1996 | CA2196062A1 Benzodiazepine derivatives |
| 02/15/1996 | CA2195965A1 Hsv viral vector |
| 02/15/1996 | CA2195107A1 Azetidine, pyrrolidine and piperidine derivatives |
| 02/15/1996 | CA2172986A1 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
| 02/14/1996 | EP0696583A1 Benzimidazolesulfonamide derivatives and pharmaceutical composition |
| 02/14/1996 | EP0696578A2 Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or blockers of calcium channels |
| 02/14/1996 | EP0696577A1 Synthetic excitatory amino acids |
| 02/14/1996 | EP0696291A1 Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments |
| 02/14/1996 | EP0696289A1 Benzo f]quinoxalindione derivatives, their preparation and their use in drugs |
| 02/14/1996 | EP0696288A1 Quinoxalindione derivatives, their preparation and their use in drugs |
| 02/14/1996 | EP0696205A1 Use of neuro-derived fetal cell lines for transplantation therapy |
| 02/14/1996 | EP0696201A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 02/14/1996 | EP0696194A1 Use of indole derivatives as 5ht1 antagonists |
| 02/14/1996 | CN1116823A Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 02/14/1996 | CN1116822A Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
| 02/14/1996 | CN1116545A Brain-refreshing analgesic powder medicine |
| 02/14/1996 | CN1116537A Traditional Chinese medicine composition for treating refractory headache |
| 02/14/1996 | CN1116525A 透皮吸收制剂 Transdermal preparations |
| 02/14/1996 | CN1116521A Sustained release compositions and a method of preparing pharmaceutical compositions |
| 02/14/1996 | CN1030986C Process for pyrrolopyrazine |
| 02/13/1996 | US5491241 Bicyclic intermediates for excitatory amino acid receptor antagonists |
| 02/13/1996 | US5491236 (1,2N) and (3,2N)-carbocyclic-2-amino tetralin derivatives |
| 02/13/1996 | US5491169 Amino acid derivatives and their therapeutical applications |
| 02/13/1996 | US5491147 Tri-substituted phenyl derivatives and their use in pharmaceutical compositions and methods of treatment |
| 02/13/1996 | US5491142 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 02/13/1996 | US5491141 Enzyme inhibitors, hypertensive agents; treating diuretic, congestive heart failure, aldosteronism, renal diseases, glaucoma |
| 02/12/1996 | CA2154977A1 Benzimidazolesulfonamide derivatives and pharmaceutical composition |
| 02/08/1996 | WO1996003501A1 Dual hybrid system |
| 02/08/1996 | WO1996003430A1 Organic compounds |
| 02/08/1996 | WO1996003421A1 Neurologically active aminosteroids |
| 02/08/1996 | WO1996003415A1 Human potassium channel 1 and 2 proteins |
| 02/08/1996 | WO1996003400A1 4-indole derivatives as serotonin agonists and antagonists |
| 02/08/1996 | WO1996003399A1 Dihydrobenzofuranes |
| 02/08/1996 | WO1996003396A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 02/08/1996 | WO1996003388A1 1,2-substituted imidazolyl compounds for the treatment of inflammation |
| 02/08/1996 | WO1996003385A1 3,4-substituted pyrazoles for the treatment of inflammation |
| 02/08/1996 | WO1996003377A1 Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors |